Psychophysiological responses to visceral and somatic pain in functional chest pain identify clinically relevant pain clusters by Farmer, A.D. et al.
Psychophysiological responses to visceral and somatic
pain in functional chest pain identify clinically relevant
pain clusters
A. D. FARMER,* S. J. COEN,*,† M. KANO,*,‡ H. NAQVI,* P. A. PAINE,§,¶ S. M. SCOTT,* P. L. FURLONG,**
S. L. LIGHTMAN,†† C. H. KNOWLES* & Q. AZIZ*
*Centre for Digestive Diseases, Blizard Institute, Wingate Institute of Neurogastroenterology, Barts and the London School
of Medicine & Dentistry, Queen Mary University of London, London, UK
†Department of Neuroimaging, Institute of Psychiatry, King’s College London, London, UK
‡Behavioural Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
§Gastrointestinal Sciences, University of Manchester, Manchester, UK
¶Salford Royal Foundation NHS Trust, Salford, UK
**Aston Brain Centre, School of Life and Health Sciences, Aston University, Birmingham, UK
††Henry Wellcome Laboratories for Integrative Neuroscience & Endocrinology, University of Bristol, Bristol, UK
Key Messages
• Functional chest pain of presumed esophageal origin is a complex but incompletely understood disorder.
• Here we demonstrate differences in personality and anxiety traits and pain tolerance thresholds to visceral and
somatic pain between patients and healthy controls.
• Patients also largely segregate into a specific “pain cluster.”
Abstract
Background Despite chronic pain being a feature of
functional chest pain (FCP) its experience is variable.
The factors responsible for this variability remain
unresolved. We aimed to address these knowledge
gaps, hypothesizing that the psychophysiological pro-
files of FCP patients will be distinct from healthy
subjects. Methods 20 Rome III defined FCP patients
(nine males, mean age 38.7 years, range 28–59 years)
and 20 healthy age-, sex-, and ethnicity-matched
controls (nine males, mean 38.2 years, range 24–49)
had anxiety, depression, and personality traits
measured. Subjects had sympathetic and parasympa-
thetic nervous system parameters measured at
baseline and continuously thereafter. Subjects
received standardized somatic (nail bed pressure)
and visceral (esophageal balloon distension) stimuli to
pain tolerance. Venous blood was sampled for cortisol at
baseline, post somatic pain and post visceral pain. Key
Results Patients had higher neuroticism, state and
trait anxiety, and depression scores but lower extro-
version scores vs controls (all p < 0.005). Patients
tolerated less somatic (p < 0.0001) and visceral stim-
ulus (p = 0.009) and had a higher cortisol at baseline,
and following pain (all p < 0.001). At baseline,
patients had a higher sympathetic tone (p = 0.04),
whereas in response to pain they increased their
parasympathetic tone (p ≤ 0.008). The amalgamating
the data, we identified two psychophysiologically
distinct ‘pain clusters’. Patients were overrepresented
in the cluster characterized by high neuroticism, trait
anxiety, baseline cortisol, pain hypersensitivity, and
parasympathetic response to pain (all p < 0.03).
Conclusions & Inferences In future, such delineations
in FCP populations may facilitate individualization of
treatment based on psychophysiological profiling.
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INTRODUCTION
Functional chest pain (FCP) of presumed esophageal
origin is characterized by recurrent unexplained mid-
line chest pain. The Rome III diagnostic criteria
include at least 3 months of symptoms, with onset at
least 6 months prior to diagnosis, in the absence of
another cause.1 Patients often demonstrate a signifi-
cant reduction in quality of life, have recourse to
disproportionately high healthcare utilization, which
itself is often manifested in recurrent negative inves-
tigations across a multitude of medical specialties, and
are frequently recalcitrant to standard therapies.2
The pathophysiological mechanisms proposed to
account for the genesis, and maintenance, of symp-
toms in FCP are incompletely understood.3 To date,
three mechanisms in particular have been subject to
objective evaluation. Firstly, esophageal hypersensitiv-
ity, first described in 1986 by Richter et al. and
subsequently confirmed by others, is considered to be
a pathophysiological feature albeit with insufficient
specificity and sensitivity for routine diagnostic use in
clinical practice.4–6 Nevertheless, this observation has
spawned further research suggesting that a combina-
tion of an increase in afferent pathway sensitivity,
abnormal cortical processing or pain hypervigilance
may account for this epiphenomenon.7 Secondly, the
stress-responsive physiological systems, namely,
the autonomic nervous system (ANS), comprising of
the parasympathetic (PNS) and sympathetic nervous
systems (SNS), and the hypothalamic-pituitary-adrenal
(HPA) axis, act as brain–body interfaces and are thus
critical components of physiological adaption in
response to changes in the external and internal
environments. It is therefore not surprising that dys-
function within these systems has been implicated as a
pathophysiological feature in a number of functional
disorders including NCCP.8 Finally, up to 61% of FCP
patients display a degree of psychological comorbidity,
which itself may enhance esophageal perception pos-
sibly through hypervigilance.9,10 Whether psychiatric
comorbidity is a primary cause, a predisposing factor,
a comorbid illness or indeed a sequelae, remains to be
fully determined.
Therefore, research is warranted to further charac-
terize its many pathophysiological features within a
single paradigm. Arguably, almost on a de rigueur
basis, the majority of the previous studies have largely
examined these features in isolation of one another and
thus such a reductionist approach has constrained our
understanding of their corelationships within possible
‘pain clusters’. In a recent study, we have demon-
strated, in health, the existence of two temporally
stable multifaceted pain clusters.11 The first of these,
accounting for ~1/3rd of the healthy population, at
baseline had higher neuroticism/anxiety scores, SNS
tone and cortisol levels but during pain had lower pain
thresholds with a concomitant increase in PNS tone.
The second cluster, accounting for the remainder, had
the converse profile at baseline and during pain.
Furthermore, these clusters exhibited differences in
polymorphisms of the serotonin transporter linked
polymorphic region and brain processing. Thus, the
primary aim of our study was to identify key psycho-
physiological profiles in patients with FCP within a
single experimental protocol and we reasoned that
psychophysiological characteristics of the first pain
cluster we have previously described in health would
be more prevalent in the patient population.
MATERIALS AND METHODS
Subjects
20 FCP patients, defined according to the Rome III criteria, and
20 healthy age-, sex-, ethnicity-matched healthy controls, sep-
arate from our previous study, were enrolled into the current
study.1 Patients were identified from the gastrointestinal (GI)
physiology database at the Royal London Hospital and healthy
controls were recruited, on an approximate matched aged basis,
from the residents of the surrounding geographical area. Within
12 months of the study, all patients had a negative cardiac
evaluation (either a negative exercise tolerance test or coronary
angiogram) with normal esophageal motility demonstrated on
high-resolution manometry, normal 24 h pH-metry, off antise-
cretory therapy, and a normal esophago-gastro-duodenoscopy
with normal biopsies from the mid- and distal esophagus.
Patients were excluded if they fulfilled another Rome III
diagnosis for a separate functional GI disorder (FGID). All
subjects were na€ıve to the experimental protocol but received
written information beforehand and provided written informed
consent. Females were studied in the follicular phase of their
menstrual cycle. Subjects were excluded if they were taking any
analgesics, centrally acting medications or those influencing
autonomic responses. Current smokers (six patients [four males],
zero healthy controls) were asked not to smoke for 24 h before
the study. Subjects were asked to refrain from alcohol con-
sumption for 24 h prior to the study. All subjects were screened
for subclinical anxiety and depression using the validated
Hospital Anxiety and Depression Scale (HADS) and healthy
subjects were excluded if their scores exceeded 7 on either
anxiety (HADS-A) or depression (HADS-D) scale.12 All subjects
were screened for comorbid chronic pain/somatoform disorders.
As several measures in the study were questionnaire based,
those who exceeded a self-deception score, as assessed by the
Weinberger Adjustment Inventory, were excluded from the
analysis thus ensuring response integrity.13 These studies were
approved by the East London and the City Ethics Committee 2
(Ref: 08/H0703/47).
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Personality and anxiety measures
The validated big five inventory (BFI) was used to measure the
personality traits of neuroticism (BFI-N) and extroversion
(BFI-E).14 State (STAI-S) and trait (STAI-T) anxiety was assessed
using the validated Spielberger State-Trait Anxiety Inventory.15
These measures were chosen based on our previous study.11
Pain induction measures
Visceral pain induction Subjects were intubated, without local
anesthetic, with an esophageal catheter (Sandhill Scientific,
Oxford, UK), containing a silicone balloon mounted 1 cm from
the distal catheter tip, which was positioned in the distal
esophagus, 34 cm ab nares. Painful stimulation was achieved
by manually inflating the balloon at a rate of 5 mls/s to the
subject’s pain tolerance threshold (PTT), which was defined as
the point at which the subjects could not tolerate any further
increase in stimulus intensity. The catheter was secured in
position using adhesive tape (Micropore, 3M Healthcare,
Bracknell, UK) applied to the subject’s nose, upper lip, and face
to minimize any distal displacement of the catheter during pain
induction. Somatic pain induction - a strain gauge (Mecmesin,
Oxford, UK) was mounted onto a spring-loaded device such that
the extension probe incorporated a thin blunt rod (Medical
Physics Department, Hope Hospital, Manchester, UK).14 This
device was applied to the right thumbnail, 5 mm from the
cuticle, producing a stimulus of nail bed force ranging from touch
to painful. Force was measured in Newtons (N). Each painful
somatic stimulus was achieved by applying nail bed force
manually to the subject’s PTT.
ANS measures
Blood pressure Digital arterial blood pressure (BP) was measured
non-invasively using the validated photoplethysmographic
technique (Portapres, Amsterdam, The Netherlands).16,17
Skin conductance responses Skin conductance is a putative
sympathetic ‘emotional sudomotor’ measure response within
milliseconds to threatening stimuli.18 Skin on the distal digit
pulp of the right index and ring fingers was wiped with water and
allowed to dry. In each subject, skin conductance electrodes were
then attached and the skin conductance level was zeroed using a
commercially available bioamp (Powerlab, AdInstruments,
Oxford, UK). The mean skin conductance response (SCR) was
extracted and analyzed offline.
Heart rate, cardiac vagal tone, and cardiac sensitivity to the
baroreflex Electrocardiogram (ECG) electrodes (Ambu Blue
Sensor P, Ballerup, Denmark) were placed in right and left
subclavicular areas and cardiac apex. The ECG was acquired
using a commercially available biosignals acquisition system
(NeuroscopeTM, Medifit Instruments, Enfield, UK). The Neuro-
scope measures brainstem PNS efferent activity, known as cardiac
vagal tone (CVT), in real time and is measured on a validated
linear vagal scale (LVS), where 0 represents full atropinization.19
The Neuroscope also incorporates beat-to-beat R-R interval and
mean BP (MBP) into an algorithm on a 10-s cycle, calculating
cardiac sensitivity to the baroreflex (CSB), an indirect measure of
PNS afferent activity.20 These measures are described in detail
elsewhere,14 but in contrast to power spectral analysis of heart
rate variability, are validated for time epochs of less than 1 min.14
Pain evoked dynamic peri-stimulus pain-related change in auto-
nomic variables was examined by calculating Dchange by com-
paring the 30 s pre- vs the 30 s poststimulus; time points
considered to demonstrate the maximal change in these param-
eters and thus utilizing the improvements in temporal resolution
conferred by the Neuroscope.14 Autonomic parameters were
recorded according to internationally agreed guidelines.21
Serum cortisol measurement
Serum total cortisol was assayed by the Blood Services Depart-
ment at the Royal London Hospital, London, UK, using a
chemiluminescence immunoassay (Nichols Advantage, San Juan,
CA, USA). In this study, 90–95% of total cortisol in the plasma is
inactive and bound to cortisol binding globulin and to a lesser
extent albumin. The remaining 5% is active and available for
access to extracellular fluid and intracellular glucocorticoid
receptors and is a validated measure of HPA axis activation.22
Experimental protocol
All subjectswere studied in the afternoon (from14:00 to 16:00 h) in a
temperature-controlled (20–22 °C), quiet laboratory. Subjects com-
pleted the questionnaires and were reclined at 45° on a couch.
Subsequent to the attachment of ANS recording equipment, 5 min
of baseline autonomic data (resting/no stimulation) was acquired.
Venous blood was sampled for baseline serum cortisol. Seven
somatic stimuli were administered to PTT, with an interstimulus
interval (ISI) of 2 min, followed by a 15-min rest period. Subjects
were then intubatedwith the esophageal catheter and allowed to rest
for 15 min and subsequently received seven esophageal stimuli,
with an ISI of 2 min, to PTT. Subjects rated each stimulus for
intensity (0 no sensation to 10 worst imaginable intensity) and
unpleasantness (0 no unpleasantness to 10 worst imaginable
unpleasantness) on a verbal report scale. Somatic and visceral
stimulus toleration and ratingswere derived from themean for each.
Subjects received a verbal cue 5 s prior to each stimulus delivery to
attempt to standardize any effects of anticipation. Venous blood was
further sampled for cortisol 2 min after thefinal somatic and visceral
stimulus. The experimental protocol is summarized in Fig. 1.
Data analysis
Categorical variables are expressed as percentages and
Chi-squared tests/Fisher’s exact tests were used to compare
groups. Continuous variables were expressed as mean  SEM.
Autonomic nervous system and HPA axis data were normally
distributed and group comparison was undertaken using a two-
tailed Student’s t-test. Mann–Whitney U-tests were used to
compare personality trait scores. To potentially stratify pain
clusters, two-step cluster analysis, amalgamating both the patient
and healthy control data, was used. Two-step cluster analysis is a
validated robust multivariate statistical method that can analyze
large datasets.23 In the first step, cases are assigned into preclus-
ters and these preclusters are treated as single cases in the second
step where a hierarchical algorithm is used to cluster the
preclusters. The two-step cluster does not require the investigator
to make any assumptions regarding the optimum number of
clusters, as it generates these automatically.24 The cluster quality
is evaluated by the silhouette coefficient, a measure of cohesion
and separation, with a coefficient >0.5 representing good separa-
tion.25 Input factors of BFI-N, BFI-E, baseline CVT, and change in
CVT to visceral and somatic pain were defined a priori based on
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our previous studies.11,26 There is no consensus as to the
optimum sample size to perform a cluster analysis27 but it is
recommended that minimal sample size includes no less than 2k
cases (k = number of input variables), in which this study
exceeded.28 All tests were two tailed, and p < 0.05 was adopted
as the statistical criterion. Analyses were performed using
proprietary software (GraphPad Prism 5, La Jolla, CA, USA and
SPSS 18, IBM, New York, NY, USA).
RESULTS
Twenty patients (nine males, mean age of 38.7 years,
range 28–59 years) and 20 healthy volunteers were
recruited to the study (nine males, mean age of
38.2 years, range 24–49 years). All subjects were cau-
casian. Two patients did not complete the study. One
(male, aged 28.4 years) was excluded as he exceeded
the self-deception score, and the other (female, aged
44.2 years) did not tolerate esophageal intubation. All
healthy volunteers completed the study.
Psychological characteristics
In comparison with healthy controls, patients had
higher anxiety and depression scores, as assessed by the
HADS, higher neuroticism, state and trait anxiety with
lower extroversion scores, see Table 1. The psycholog-
ical characteristics of the patients who completed the
study were not significantly different to those that
were either excluded/did not tolerate esophageal
intubation.
Behavioral responses to pain
The mean somatic stimulus tolerated by patients was
48.4 N  3.4 vs 70.61 N  3.6 by the controls
(p < 0.0001). The mean visceral stimulus tolerated by
patients was 30 mls  1.8 vs 50.9 mls  6.9 for the
controls (p = 0.009). There was no difference in the
Table 1 The psychological state and trait characteristics of patients in






Mean  SEM p value
HADS – A 4.65  0.47 2.45  0.34 0.0005
HADS – D 4.82  0.63 1.9  0.36 0.0002
BFI-N 3.67  0.25 2  0.36 0.0001
BFI-E 3.04  0.42 4.2  0.23 0.003
STAI-T 43.5  2.47 28.4  8.5 0.009
STAI-S 41.7  2.6 27.7  2.2 0.0007
Figure 1 A schematic summary of the psychophysiological experimental protocol.
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somatic pain intensity and unpleasantness ratings
between patients and controls (7.72  0.29 vs
7.62  0.31, p = 0.81 and 6.26  0.24 vs 6.28  0.3,
p = 0.94, respectively). Similarly, there was no difference
in the visceral pain intensity and unpleasantness rating
between patients and controls (7.26  0.25 vs 7.62  0.47,
p = 0.51 and 7.44  0.28 vs 7.39  0.44, p = 0.93).
Hypothalamic-pituitary-adrenal axis responses to
pain
Serum cortisol was higher in patients at baseline and
following somatic and visceral pain, see Fig. 2.
Although there was no significant difference in the
absolute increase in cortisol post pain between patients
and controls, the levels in the patients began at very
high values for the afternoon, and unlike the levels in
control subjects reached concentrations associated
with a significant stress response.29
Baseline ANS parameters
At baseline, patients had an elevated heart rate
(75.9  4.7 vs 67.2  1.7, p = 0.04) and SCR
(4.2  0.9 vs 2.05  0.22, p = 0.04) with lower CVT
(5.5  0.84 vs 11.76  1.6, p = 0.003) and CSB
(4.79  0.92 vs 8.76  1.27, p = 0.02) in comparison
with controls. At baseline, no differences were
apparent in BP.
ANS responses to pain
In response to somatic pain, patients’ heart rate
increased less than controls, with a concomitant
reduction in systolic BP and a marked increase in
parasympathetic tone (CVT and CSB), which was not
evident in the controls (see panels A and B, respec-
tively, see Fig. 3). To visceral pain, patients compared
to controls slowed their heart rate, decreased systolic
BP, increased PNS tone (CVT and CSB) (see panels C
and D, respectively, see Fig. 2), but withdrew SNS tone
(SCR), see Table 2.Figure 2 Serum cortisol at baseline, post somatic pain and post
visceral pain in patients and controls, all differences p < 0.01.
Figure 3 Peri-stimulus dynamic changes in
efferent and afferent parasympathetic tone
(CVT and CSB, respectively) to somatic pain
(A and B) and to visceral pain (C and D)
between patients and controls. Patients
increased their parasympathetic tone to
somatic and visceral pain whereas controls
withdrew it. * Statistically significant at
p < 0.001.
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Cluster analysis reveals clinically relevant pain
clusters
The optimum solution for the amalgamated dataset
was two clusters, with cluster 1 containing 22 subjects
(57.9%) and cluster 2 containing 16 subjects (42.1%),
hereinafter termed pain cluster 1 and pain cluster 2.
The relative predictor importance of the input vari-
ables to the two-step cluster analysis is shown in
Fig. 4. The cluster silhouette coefficient was 0.61. The
silhouette coefficient maybe interpreted as between
1, indicating a very poor model, and 1, indicating an
excellent model. An average silhouette greater than 0.5
indicates reasonable partitioning of data.30 Further
comparisons between the two pain clusters are shown
in Table 3.
In summary, cluster 1 at baseline had higher
neuroticism and trait anxiety scores with lower extro-
version scores and also lower PNS tone. In response to
somatic pain, cluster 1 tolerated lower stimulus
thresholds, had higher cortisol, and displayed a
dynamic increase in PNS tone with concomitant SNS
withdrawal. Similarly in response to visceral pain,
similar patterned responses were observed, although
differences in cortisol did not reach statistical signif-
icance. Cluster 2 displayed the converse profile. In
cluster 1, there were 15 patients and seven controls and
in cluster 2 there were three patients and 13 controls
(p = 0.004, relative risk 3.6, 95% confidence interval
1.3–10.5). Derived from this data, the probability
distribution was highly significant (p < 0.0001) with a
sensitivity of 0.83 (95% confidence interval 0.7–0.9)
and specificity of 0.65 (95% confidence interval
0.55–0.7).
DISCUSSION
We have demonstrated differences in personality traits,
somatic and visceral sensitivity, HPA axis, and ANS
Table 3 Psychophysiological differences between the pain clusters.
Demographic, personality traits, baseline autonomic, visceral, and







Mean (SEM) p value
Personality traits
BFI neuroticism 3.7  0.24 1.95  0.15 <0.0001*
BFI extroversion 2.92  0.26 4.36  0.15 0.0002*
STAI-T 41.6  32.4 30.3  2.89 0.007*




343.2  23.25 239.7  37.32 0.03*
Postsomatic pain
cortisol (nM)
418.1  22.75 292.6  54.29 0.04*
Postvisceral pain
cortisol (nM)
449.7  33.35 316.4  55.8 0.054
Baseline ANS
CVT (lvs) 5.15  0.68 12.16  1.5 0.0005*
SCR (lS) 2.08  0.49 2.78  0.12 0.43
Somatic pain ANS responses
Mean stimulus (N) 57.6  2.89 72.8  2.1 0.0001*
DCVT (%) 47.67  14.58 12.3  4.6 0.001*
DSCR (%) 0.01  0.9 4.99  0.9 0.009*
Visceral pain ANS responses
Mean stimulus (mL) 30.1  2.11 44.3  2.45 0.0009*
DCVT (%) 94.01  31.22 15.43  3.5 0.002*
DSCR (%) 1.22  0.42 3.8  0.9 0.01*
*Statistically significant.
Figure 4 A graphical summary of the relative importance of the input
factors (BFI neuroticism, BFI extroversion, change in cardiac vagal tone
to somatic and visceral pain and baseline cardiac vagal tone) to the
composition of the clusters. For example, BFI neuroticism relative
importance was 1.0 compared to baseline cardiac vagal tone of 0.1
suggesting that this psychological trait is 910 more important in
delineating the clusters.
Table 2 Dynamic peri-stimulus change in autonomic parameters to




Mean (SEM) p value
Peri-stimulus dynamic changes in ANS parameters to somatic pain
DHR (%Dbpm) 0.27  1.4 8.3  2.6 0.01*
DSBP (%DmmHg) 0.27  0.6 2.9  1.1 0.03*
DDiastolic BP
(%DmmHg)
1.07  0.68 2.8  1.08 0.18
DMBP (%DmmHg) 1.22  0.45 3.12  0.99 0.07
DCVT (%DLVS) 53  18.6 14.1  5.2 0.002*
DCSB (%DDRR/
DmmHg)
13.24  6.3 24.8  11.7 0.01*
DSCR (%DlS) 0.09  1.7 15.88  1.4 0.007*
Peri-stimulus dynamic changes in ANS parameters to visceral pain
DHR (%Dbpm) 1.69  1.2 5  1.35 0.002*
DSBP (%DmmHg) 1.66  0.9 3.5  1.4 0.008*
DDiastolic BP
(%DmmHg)
0.98  1.1 3.1  1.66 0.06
DMBP (%DmmHg) 0.85  0.9 3.6  1.7 0.02*
DCVT (%DLVS) 105.7  38 15.9  4.5 0.008*
DCSB (%DDRR/
DmmHg)
36.97  17 21.8  8.5 0.008*
DSCR (%DlS) 0.73  0.2 12.78  0.8 0.006*
*Statistically significant.
© 2013 John Wiley & Sons Ltd6
A. D. Farmer et al. Neurogastroenterology and Motility
parameters at baseline and in responses to pain in
Rome III defined FCP within a single experiment.
Patients had higher anxiety, neuroticism scores, and
tolerated less mean somatic and visceral stimulus in
comparison with the controls. Furthermore, cluster
analysis defined two homogeneous pain clusters,
which we believe may have clinical salience. Our
discussion will focus on three important aspects to be
derived from this study. Firstly, we will examine the
pathophysiology of FCP including the role of hyperal-
gesia, personality traits and HPA axis/ANS responses.
Secondly, we shall conjecture as to the importance of
the pain clusters with respect to the current literature.
Finally, we shall suggest some practical and clinical
applications for the future.
We have demonstrated that patients with FCP have
reduced tolerance to both somatic and visceral pain
thus suggesting a degree of hyperalgesia across these
modalities. It is interesting to observe that rating of
pain intensity and unpleasantness were not different
between patients and healthy controls and is likely to
be the consequence of the instruction given to partic-
ipants to tolerate the stimulus to PTT. However, we
would acknowledge that the hyperalgesia observed
could be, in part, explained by elevated state anxiety
that was observed in the patient group. Our observation
of esophageal hyperalgesia is consistent with that of
Rao et al. who demonstrated that patients with FCP
demonstrate lower esophageal pain thresholds to bal-
loon distension compared to controls.31 To date, how-
ever, there is a paucity of studies evaluating whether
hyperalgesia is limited to the esophagus in FCP per se
or is more generalized. In contrast, in patients with
irritable bowel syndrome, where visceral hypersensi-
tivity is a frequently reported phenomenon, somatic
pain and hyperalgesia often coexist, which may be
explained by the presence of concomitant somatic pain
disorders such as fibromyalgia.32 We have previously
shown that N-methyl-D-aspartate receptor blockade
reverses acid induced esophageal and somatic hyperal-
gesia suggesting that central sensitization is a plausible
mechanism for viscerosomatic hyperalgesia.33 It is
therefore intriguing to speculate that the visceroso-
matic hyperalgesia seen in our FCP patients may have a
similar mechanistic basis although the influence of
psychological factors cannot be discounted.
Although previous work has demonstrated higher
levels of anxiety, depression, and affective stress in
FCP patients, we have additionally observed higher
neuroticism and lower extroversion scores.34 Specific
personality traits and psychopathology, such as anxiety
and somatoform disorders, are overrepresented in
patients with FCP.35 However, hitherto none of these
personality or anxiety traits have been reliably segre-
gated with any objective physiological characteristics
in FCP. While neuroticism, extroversion, and anxiety
are all traits that are distributed on a continuous scale,
and thus do not represent psychopathology per se, it is
interesting to note the significant differences do exist
between patients and controls.
Dysfunction of the HPA axis is among the most
investigated biological risk marker in functional
somatic (FSD) and FGID. Although in our current
study there was no significant difference in the abso-
lute change in cortisol between the two groups, the
patient group started at remarkably high levels of
cortisol for the time of day (mid-afternoon) and
following the painful stimuli reached levels of cortisol
normally only found at the peak of morning pulses or
following an acute stressor.36 These high levels suggest
increased basal activity of the HPA axis with further
responsiveness to painful stimuli. It is possible that
some of this may reflect the differential state anxiety
scores between patients and controls. For example,
Ritsner et al. demonstrated in both healthy volunteers
and patients with psychiatric comorbidity that base-
line cortisol is related to anxiety levels.37 In conjunc-
tion with other data presented herein, we postulate
that a common central pathway may link anxiety
levels with activation of the HPA axis. However, these
observations must be tempered by a recent meta-
analysis which did not find evidence of HPA axis
dysfunction across the most common FSD and FGID,
although FCP was not included.38
We have shown that at baseline patients had higher
HR and SCR with lower CVT in comparison with
controls, suggesting higher SNS and lower PNS tone.
These findings are in agreement with a previous study
by Tougas et al., who observed that patients with
NCCP, who developed pain following esophageal
acidification, demonstrate higher baseline HR and
lower vagal tone8 but during acid infusion these
patients increase their vagal tone in a manner similar
to the dynamic ANS responses that were seen in our
FCP patients to visceral and somatic painful stimuli. It
is plausible to speculate that this transient increase in
parasympathetic tone to pain in patients with NCCP/
FCP, who are more sensitive to pain ab initio, could
represent a hitherto underrecognized compensatory
analgesic mechanism. Indeed, preclinical and clinical
evidence is accumulating for such a PNS-mediated
analgesic mechanism. For instance, low-energy vagal
nerve stimulation, delivered by deep brain or transcu-
taneous stimulation, produces an analgesic effect.39,40
Thus, augmentation of vagal tone, either physiologi-
cally, electrically or pharmacologically, may present a
© 2013 John Wiley & Sons Ltd 7
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novel treatment strategy in patients with symptoms
unresponsive to standard interventions.41
Using cluster analysis, we further demonstrate the
presence of two pain clusters. The first of these,
accounting for 35% of our healthy subjects, but over
83% of FCP patients, can be characterized as having
higher neuroticism and anxiety scores with elevated
baseline SNS & HPA axis tone. These subjects had
lower pain thresholds and had an attenuated HR
response and increased their PNS tone to pain. In
contrast, the second cluster, accounting for 65% of our
healthy population, yet less than 17% of FCP patients,
display the opposite profile. The external validity for
these pain clusters is derived from two strands of
evidence. Firstly, in a previous preliminary study of
healthy subjects, we identified two pain clusters with
similar psychophysiological characteristics.26 Sec-
ondly, more recently in a larger cohort of 120 healthy
subjects, we have replicated these initial findings and
demonstrated temporal stability.11 Furthermore, the
proportions of healthy subjects that segregated to pain
clusters 1 and 2 were similar to our previous published
work.
It is interesting to cogitate as to the neurobiological
basis of these pain clusters. It can be argued that the
pain cluster 1 displayed hypervigilant ‘tonic-freeze’
response to pain, characterized by an increase in PNS
tone, whereas pain cluster 2 mounted a more classical
‘fight-flight’ response, characterized by an increase in
SNS tone. Data from studies of animal behavior
surmise that the ‘tonic-freeze’ response may reflect a
more anxious or reactive coping style whereas the
‘fight-flight’ response is a more proactive coping
style.42 These differences in coping styles may
potentially underpin survival strategies imparted by
behavioral flexibility.43
It is intriguing that many factors identified in our
pain clusters have been implicated as features and risk
factors for other chronic pain syndromes.44–46 Our
study therefore provides preliminary evidence that
patients with FCP are overrepresented in the first of
these pain clusters and further studies are needed to
establish the salience of these in a larger group of
patients. Likewise, longitudinal studies in healthy
populations are also needed to evaluate whether the
factors identified in our first pain cluster do represent a
conglomerate risk factor for the development of wider
FSD or FGID, particularly when an appropriate
biopsychosocial challenge occurs.
It may be argued that the psychophysiological profile
we have observed in this study is not specific to FCP
per se as our cluster analysis in the current and
previous study reveals that some healthy subjects also
have a similar profile. However, as mentioned above,
the traits observed in cluster 1 appear to be present in
approximately one-third of healthy subjects but more
than 80% of patients with FCP. It is intriguing to note
that about a third of patients who experience somatic
or visceral injury/inflammation, such as thoracic sur-
gery or infectious gastroenteritis, go on to develop
chronic pain.47,48 It is plausible therefore to speculate
that the psychophysiological profile in cluster 1 may
represent a biomarker of susceptibility to develop
chronic pain when the appropriate environmental
challenge occurs and thus this profile is unlikely to
be specific for any one visceral or somatic pain
syndrome. This speculation will of course require
confirmation in future studies.
The potential clinical utility of these pain clusters
remains to be fully realized but may be far reaching.49
Utilizing such an approach may facilitate the develop-
ment of aggregated biomarkers, an area that has been
recently highlighted by a multinational initiative.50
Furthermore, pain clusters may allow the stratification
of FCP patients toward an individualization of thera-
peutic interventions. For example, patients in the first
pain cluster, who have higher neuroticism and anxiety
scores, may preferentially respond to psychological
treatments in comparison with those in the second
who may have an enhanced response to pharmacolog-
ical interventions. Moreover, a similar strategy may be
beneficial in other FGID considering the substantial
overlap between pathophysiological features and the
frequent coexistence of multiple FGIDs within a single
patient.51 In conclusion, this is the first report exam-
ining the salience of pain clusters in a chronic visceral
pain syndrome. Further studies are now warranted to
address the knowledge gaps that remain, particularly
directed toward whether the individualization of strat-
ification of treatment between the pain clusters
improves outcomes.
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